WHO ICTRP trial
Neoadjuvant QL1706-Based Combination Chemotherapy for Locally Advanced Oral…
ChiCTR2500113229 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113229 |
|---|---|
| Public title | Neoadjuvant QL1706-Based Combination Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma: A Prospective, Single-Arm, Multicenter Exploratory Study |
| Scientific title | Neoadjuvant QL1706-Based Combination Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma: A Prospective, Single-Arm, Multicenter Exploratory Study |
| Primary sponsor | The First Affiliated Hospital of Fujian Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Oral Squamous Cell Carcinoma: |
| Interventions | Experimental group:QL1706, 5 mg/kg, iv, Q3W Albumin-bound paclitaxel, 260 mg/m2, iv, Q3W Cisplatin, 75 mg/m2, iv, Q3W |
| Registration date | Nov 26, 2025 |
| Target size | Experimental group:36 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: